Viridian Therapeutics, Inc.\DE - VRDN

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$2.407B
QoQ value delta ($000)
-$950.2M (-28.3%)
Implied price effect (QoQ)
-34.94%
Shares
Total shares
118,900,997
QoQ shares delta
+11,009,632 (+10.2%)
Total shares held by funds (by quarter)

Market chart (VRDN)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 226 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
FMR LLC 300,820 15,379,377 0.02%
VANGUARD GROUP INC 174,649 5,612,144 0.0%
BlackRock, Inc. 153,183 7,831,475 0.0%
Bellevue Group AG 131,563 6,726,144 3.13%
STATE STREET CORP 91,401 4,672,885 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 81,510 4,167,201 0.0%
Fairmount Funds Management LLC 76,566 3,914,458 5.53%
Venrock Adviser, LLC 75,945 3,882,709 2.83%
PRICE T ROWE ASSOCIATES INC /MD/ 62,711 3,206,035 0.01%
Paradigm Biocapital Advisors LP 61,592 3,148,893 1.26%
WELLINGTON MANAGEMENT GROUP LLP 60,216 3,078,554 0.01%
CITADEL ADVISORS LLC 46,610 2,382,934 0.01%
Kynam Capital Management, LP 45,802 2,341,652 2.83%
GEODE CAPITAL MANAGEMENT, LLC 45,646 2,333,213 0.0%
BALYASNY ASSET MANAGEMENT L.P. 45,300 2,315,957 0.06%
ALLIANCEBERNSTEIN L.P. 43,321 1,392,072 0.01%
Novo Holdings A/S 39,120 2,000,000 3.17%
BAKER BROS. ADVISORS LP 38,566 1,971,678 0.22%
TANG CAPITAL MANAGEMENT LLC 35,063 1,792,626 1.78%
Fisher Asset Management, LLC 34,587 1,768,295 0.01%
VANGUARD PORTFOLIO MANAGEMENT LLC 32,107 1,641,477 0.0%
GOLDMAN SACHS GROUP INC 31,138 1,591,945 0.0%
Avoro Capital Advisors LLC 29,340 1,500,000 0.29%
Deep Track Capital, LP 27,265 1,393,944 0.45%
D. E. Shaw & Co., Inc. 24,695 1,262,540 0.01%